Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2018-09-28 2018-08-09
Drug Identification Number 02273373 02273373
Brand name APO-AMLODIPINE APO-AMLODIPINE
Common or Proper name AMLODIPINE AMLODIPINE
Company Name APOTEX INC APOTEX INC
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 5.0MG 5.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL & 500 BTL 100 BTL & 500 BTL
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-08-06 2018-08-06
Estimated end date 2018-10-15 2018-10-15
Actual end date 2018-09-28
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments